Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-011098)

Filing Details

Accession Number:: 0001209191-13-011098
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-02-22 19:06:51
Reporting Period:: 2013-02-20

Filing Date:: 2013-02-22
Accepted Time:: 2013-02-22 19:06:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1292519	Invivo Therapeutics Holdings Corp.	NVIV	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1503383	Francis Reynolds	C/O Invivo Therapeutics Holdings Corp. One Kendall Square, Suite B14402 Cambridge MA 02139	Ceo, Cfo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-02-20	3,000	$1.73	13,761,310	No	4	S	Direct
Common Stock	Disposition	2013-02-20	1,230	$1.75	13,760,080	No	4	S	Direct
Common Stock	Disposition	2013-02-20	20	$1.79	13,760,060	No	4	S	Direct
Common Stock	Disposition	2013-02-21	1,200	$1.64	13,758,860	No	4	S	Direct
Common Stock	Disposition	2013-02-21	50	$1.65	13,758,860	No	4	S	Direct
Common Stock	Disposition	2013-02-21	1,000	$1.68	13,757,810	No	4	S	Direct
Common Stock	Disposition	2013-02-21	1,000	$1.69	13,756,810	No	4	S	Direct
Common Stock	Disposition	2013-02-21	1,000	$1.70	13,755,810	No	4	S	Direct
Common Stock	Disposition	2013-02-22	171,000	$0.00	13,584,810	No	5	G	Direct
Common Stock	Disposition	2013-02-22	2,200	$1.64	13,582,610	No	4	S	Direct
Common Stock	Disposition	2013-02-22	660	$1.65	13,581,950	No	4	S	Direct
Common Stock	Disposition	2013-02-22	390	$1.68	13,581,560	No	4	S	Direct
Common Stock	Disposition	2013-02-22	1,000	$1.69	13,580,560	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	5	G	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	19,579	Indirect	By 401(k) Plan

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2012.